Drugs / Probiotic Formula
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT07364578 | Feb 2025 → Feb 2026 overdue | osteoarthritis, knee | Beni-Suef University | Recruiting | No outcome recorded |
| Phase 3 | NCT05629468 | Oct 2021 → Jun 2022 | acne | Pak Emirates Military Hospital | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03021161 | Jan → Dec 2017 | occupational asthma | University of Sao Paulo | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06253988 Comparator | Jan → Feb 2023 | periodontitis | Al-Azhar University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07364578 ↗ |
| Modality | Other / unclassified | “use of probiotics” NCT03021161 ↗ |
| Route | Oral | “Probiotic sachet oral once a day everyday” NCT05629468 ↗ |